Immunotherapeutic interventions of Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) is a highly heterogeneous subtype of breast cancer that lacks the expression of oestrogen receptors, progesterone receptors and human epidermal growth factor receptor 2. Although TNBC is sensitive to chemotherapy, the overall outcomes of TNBC are worse than for o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zehuan, Qiu, Yiran, Lu, Weiqi, Jiang, Ying, Wang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977468/
https://www.ncbi.nlm.nih.gov/pubmed/29848327
http://dx.doi.org/10.1186/s12967-018-1514-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977468/
https://www.ncbi.nlm.nih.gov/pubmed/29848327
http://dx.doi.org/10.1186/s12967-018-1514-7

Ejemplares similares